TABLE 2.
Ex-vivo results of the elastic properties of breast tissues, reported in literature.
Experiment | Tissue types | Experimental protocol | Results/Conclusions | Authors |
---|---|---|---|---|
Ex-vivo | Adipose | Compression tests | Compression: 5∖%; 20∖% | Krouskop et al. (1998) |
Glandular | 0.1, 1, and 4 Hz | Eadipose = 18 ± 7–22 ± 12; = 20 ± 8–24 ± 6 | ||
Fibrous DCIS | Compression of 5% and 20% | Eglandular = 28 ± 14–35 ± 14; = 48 ± 15–66 ± 17 | ||
IDC | Efibrous = 96 ± 34–116 ± 28; = 218 ± 87–244 ± 85 EDCIS = 22 ± 8–26 ± 5; 291 ± 67–307 ± 78 EIDC = 93 ± 33–112 ± 43; 460 ± 178–558 ± 180 | |||
Adipose | Indentation tests 2N load for 10 cycles Strain rate: 50, 200, 1,000% and 2000%/s | Strain: from 0.01 to 0.15 | Wellman et al. (1999) | |
Glandular | Eadipose = 4.8 ± 2.5–17.4 ± 8.4 | |||
Phyllodes tumor | Eglandular = 17.5 ± 8.6–271.8 ± 167.7 | |||
Papilloma | Ephyllodes = 56.6–297.7 | |||
Lobular carcinoma | Epapilloma = 22.2 ± 5.8–537.8 ± 209.1 ELC = 34.7–628.4 | |||
Fibroadenoma IDC | Efibroadenoma = 45.5 ± 20.1–889.2 ± 205 EIDC = 47.1 ± 19.8–1,366.5 ± 348.2 EDCIS = 71.2–2,162.1 | |||
DCIS | ||||
Adipose | Indentation tests | Eadipose = 1.9 kPa | Samani et al. (2003) | |
Fibroglandular | Preload = 0.5–2.0 g | Efibroglandular = 1.8 kPa | ||
High grade DC | 0.5 mm and 0.02–0.1 Hz | Ecarcinoma = 12.0 kPa | ||
Preconditioning: 25 cycles + Test: 5 cycles | ||||
Fibroadenoma | Indentation tests | Efibroadenoma = 11.42 ± 1.56 kPa EDCIS = 14.15 ± 0.35 kPa EILC = 18.57 ± 0.85 kPa EIDC = 22.55 ± 2.95 kPa | Samani and Plewes (2007) | |
High grade DCIS | Preload = 0.01–0.03 N | |||
Infiltrating LC | 0.5 mm and 0.1 Hz | |||
IDC | Preconditioning: 25 cycles + Test: 5 cycles | |||
Adipose | Indentation tests Preload = 3.0 g 0.5 mm and 0.1 Hz Preconditioning: 25 cycles + Test: 5cycles | Eadipose = 3.25 ± 0.91 | Samani et al. (2007) | |
Fibroglandular | Efibroglandular = 3.24 ± 0.61 | |||
Fibroadenomas | Efibroadenoma = 6.41 ± 2.86 | |||
Low grade IDC | ElowIDC = 10.40 ± 2.6 EILC = 15.62 ± 2.64 EDCIS = 16.38 ± 1.55 | |||
ILC | ||||
DCIS | ||||
Fibrocystic disease | Efibrocystic = 17.11 ± 7.35 | |||
Intermediate grade IDC | EintIDC = 19.99 ± 4.2 | |||
High grade IDC | EhighIDC = 42.52 ± 12.47 EIMC = 20.21 | |||
IMC | ||||
Fat necrosis | Enecrosis = 4.45 | |||
Adipose | Indentation test Up to 30% strain at 1 mm/min (50% for fat or gland) | Eadipose = 0.69 ± 0.19–19.08 ± 4.99 | Umemoto et al. (2014) | |
Glandular | Eglandular = 0.73 ± 0.18–16.99 ± 4.92 | |||
IDP | EIDP = 3.13 ± 1.74–12.30 ± 4.29 | |||
DCIS | EDCIS = 5.25 ± 0.46–16.15 ± 4.24 | |||
Invasive carcinomas | Einvasive = 13.82 ± 9.60–30.50 ± 11.46 | |||
IDC, ILC, MC, Metaplastic carcinoma | ||||
Adipose | Indentation tests Up to 30% strain at 1 mm/min (50% for fat or gland) | Eadipose = 0.7 ± 0.2–17.3 ± 4.8 | Matsumura et al. (2009) | |
Glandular | Eglandular = 0.8 ± 0.2–15.4 ± 3.9 | |||
DCIS | EDCIS = 3.4 ± 1.3–15.6 ± 2.0 | |||
MCIDC | Emucinous = 9.2 ± 1.7–18.9 ± 2.3 | |||
EIDC = 11.5 ± 8.4–27.0 ± 9.2 | ||||
human DAT (breast) | Indentation tests 0.5mm and 0.1 Hz Preconditioning: 25 cycles + Test: 5 cycles | EDAT = 3.460 ± 1.210 kPa | Omidi et al. (2014) |